161 related articles for article (PubMed ID: 31631595)
41. Plumbagin inhibits cell growth and potentiates apoptosis in human gastric cancer cells in vitro through the NF-κB signaling pathway.
Li J; Shen L; Lu FR; Qin Y; Chen R; Li J; Li Y; Zhan HZ; He YQ
Acta Pharmacol Sin; 2012 Feb; 33(2):242-9. PubMed ID: 22231395
[TBL] [Abstract][Full Text] [Related]
42. Bortezomib inhibits nuclear factor-kappaB dependent survival and has potent in vivo activity in mesothelioma.
Sartore-Bianchi A; Gasparri F; Galvani A; Nici L; Darnowski JW; Barbone D; Fennell DA; Gaudino G; Porta C; Mutti L
Clin Cancer Res; 2007 Oct; 13(19):5942-51. PubMed ID: 17908991
[TBL] [Abstract][Full Text] [Related]
43. MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.
Cortes-Sempere M; Chattopadhyay S; Rovira A; Rodriguez-Fanjul V; Belda-Iniesta C; Tapia M; Cejas P; Machado-Pinilla R; Manguan-García C; Sánchez-Pérez I; Nistal M; Moratilla C; de Castro-Carpeño J; Gonzalez-Barón M; Albanell J; Perona R
Cancer Lett; 2009 Dec; 286(2):206-16. PubMed ID: 19553005
[TBL] [Abstract][Full Text] [Related]
44. Bortezomib induces apoptosis in T lymphoma cells and natural killer lymphoma cells independent of Epstein-Barr virus infection.
Iwata S; Yano S; Ito Y; Ushijima Y; Gotoh K; Kawada J; Fujiwara S; Sugimoto K; Isobe Y; Nishiyama Y; Kimura H
Int J Cancer; 2011 Nov; 129(9):2263-73. PubMed ID: 21170988
[TBL] [Abstract][Full Text] [Related]
45. Chalepin: A Compound from
Richardson JSM; Aminudin N; Abd Malek SN
Pharmacogn Mag; 2017 Oct; 13(Suppl 3):S489-S498. PubMed ID: 29142404
[TBL] [Abstract][Full Text] [Related]
46. Mechanisms underlying synergism between circularized tumor necrosis factor-related apoptosis inducing ligand and bortezomib in bortezomib-sensitive or -resistant myeloma cells.
Leng Y; Hu X; Li L; Nkwocha J; Satta T; Sharma K; Kmeiciak M; Zhou H; Zhang Z; Zhou L; Chen W; Grant S
Hematol Oncol; 2022 Dec; 40(5):999-1008. PubMed ID: 35789025
[TBL] [Abstract][Full Text] [Related]
47. NF-kappaB inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia.
Fabre C; Carvalho G; Tasdemir E; Braun T; Adès L; Grosjean J; Boehrer S; Métivier D; Souquère S; Pierron G; Fenaux P; Kroemer G
Oncogene; 2007 Jun; 26(28):4071-83. PubMed ID: 17213804
[TBL] [Abstract][Full Text] [Related]
48. Chelidonium majus L. extract induces apoptosis through caspase activity via MAPK-independent NF-κB signaling in human epidermoid carcinoma A431 cells.
Park SW; Kim SR; Kim Y; Lee JH; Woo HJ; Yoon YK; Kim YI
Oncol Rep; 2015 Jan; 33(1):419-24. PubMed ID: 25354169
[TBL] [Abstract][Full Text] [Related]
49. [NF-κB signaling pathway regulate endplate chondrocytes in rat vitro natural degeneration model].
Gao Z; Xu HG; Zhang XL; Wang H; Ma MM; Xiao L; Liu X
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(27):2182-6. PubMed ID: 27464547
[TBL] [Abstract][Full Text] [Related]
50. Bortezomib sensitizes malignant human glioma cells to TRAIL, mediated by inhibition of the NF-{kappa}B signaling pathway.
Jane EP; Premkumar DR; Pollack IF
Mol Cancer Ther; 2011 Jan; 10(1):198-208. PubMed ID: 21220502
[TBL] [Abstract][Full Text] [Related]
51. Cell death by bortezomib-induced mitotic catastrophe in natural killer lymphoma cells.
Shen L; Au WY; Wong KY; Shimizu N; Tsuchiyama J; Kwong YL; Liang RH; Srivastava G
Mol Cancer Ther; 2008 Dec; 7(12):3807-15. PubMed ID: 19074855
[TBL] [Abstract][Full Text] [Related]
52. Visfatin induces the apoptosis of endothelial progenitor cells via the induction of pro-inflammatory mediators through the NF-κB pathway.
Sun L; Chen S; Gao H; Ren L; Song G
Int J Mol Med; 2017 Sep; 40(3):637-646. PubMed ID: 28677720
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis.
Pham LV; Tamayo AT; Yoshimura LC; Lo P; Ford RJ
J Immunol; 2003 Jul; 171(1):88-95. PubMed ID: 12816986
[TBL] [Abstract][Full Text] [Related]
54. Bortezomib induces apoptosis of Epstein-Barr virus (EBV)-transformed B cells and prolongs survival of mice inoculated with EBV-transformed B cells.
Zou P; Kawada J; Pesnicak L; Cohen JI
J Virol; 2007 Sep; 81(18):10029-36. PubMed ID: 17626072
[TBL] [Abstract][Full Text] [Related]
55. Baicalin induces apoptosis in leukemia HL-60/ADR cells via possible down-regulation of the PI3K/Akt signaling pathway.
Zheng J; Hu JD; Chen YY; Chen BY; Huang Y; Zheng ZH; Liu TB
Asian Pac J Cancer Prev; 2012; 13(4):1119-24. PubMed ID: 22799292
[TBL] [Abstract][Full Text] [Related]
56. Activation of the NF-κB Pathway and Heterozygous Deletion of TNFAIP3 (A20) Confer Superior Survival in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.
Liu F; Zheng JP; Wang L; Zhao DH; Li MY; Wang YM; Liu Y; Ma J; Zeng NY; Liu HX; Liang R; Guo SP; Wang Z; Yan QG
Am J Clin Pathol; 2019 Jul; 152(2):243-252. PubMed ID: 31140551
[TBL] [Abstract][Full Text] [Related]
57. Thymoquinone inhibits growth of human medulloblastoma cells by inducing oxidative stress and caspase-dependent apoptosis while suppressing NF-κB signaling and IL-8 expression.
Ashour AE; Ahmed AF; Kumar A; Zoheir KM; Aboul-Soud MA; Ahmad SF; Attia SM; Abd-Allah AR; Cheryan VT; Rishi AK
Mol Cell Biochem; 2016 May; 416(1-2):141-55. PubMed ID: 27084536
[TBL] [Abstract][Full Text] [Related]
58. Genistein induces apoptotic cell death associated with inhibition of the NF-κB pathway in adult T-cell leukemia cells.
Yamasaki M; Mine Y; Nishimura M; Fujita S; Sakakibara Y; Suiko M; Morishita K; Nishiyama K
Cell Biol Int; 2013 Jul; 37(7):742-7. PubMed ID: 23526666
[TBL] [Abstract][Full Text] [Related]
59. LIGHT/IFN-γ triggers β cells apoptosis via NF-κB/Bcl2-dependent mitochondrial pathway.
Zheng QY; Cao ZH; Hu XB; Li GQ; Dong SF; Xu GL; Zhang KQ
J Cell Mol Med; 2016 Oct; 20(10):1861-71. PubMed ID: 27241100
[TBL] [Abstract][Full Text] [Related]
60. Diallyl trisulfide induces apoptosis by suppressing NF-κB signaling through destabilization of TRAF6 in primary effusion lymphoma.
Shigemi Z; Furukawa Y; Hosokawa K; Minami S; Matsuhiro J; Nakata S; Watanabe T; Kagawa H; Nakagawa K; Takeda H; Fujimuro M
Int J Oncol; 2016 Jan; 48(1):293-304. PubMed ID: 26647777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
